San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.
A few weeks ago, when we revisited Eric Topol's top 10 digital health predictions, Topol mentioned microfluidics -- and the ability to create home versions of medical lab tests -- as one of the ...
In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback